首页> 美国卫生研究院文献>Tissue Engineering. Part A >Regeneration of Chronic Tympanic Membrane Perforation Using an EGF-Releasing Chitosan Patch
【2h】

Regeneration of Chronic Tympanic Membrane Perforation Using an EGF-Releasing Chitosan Patch

机译:使用释放表皮生长因子的壳聚糖膜修复慢性鼓膜穿孔

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Most chronic tympanic membrane (TM) perforations require surgical interventions such as tympanoplasty because, unlike with acute perforations, it is very difficult for the perforations to heal spontaneously. The purpose of this study was to develop novel therapeutic techniques and scaffolds that release growth factors to treat chronic TM perforations. We evaluated the cell proliferation effects of the epidermal growth factor (EGF) and fibroblast growth factor (FGF) on in vitro cultures of TM cells using an MTT assay. They both showed similar efficacy, so we used EGF because of its lower cost. We then constructed an EGF-releasing chitosan patch scaffold (EGF-CPS) based on previous studies. We analyzed its toxicity and strength, and we studied it using scanning electron microscopy. EGF was released from the EGF-CPS for 8 weeks in an in vitro system. In animal studies, the EGF group, which was treated with EGF-CPS, showed healing in 56.5% of the animals (13/23), while the control group, which did not receive any treatment, revealed 20.8% healing (4/24) (p=0.04). Transmission electron microscopic studies of regenerated eardrums in the EGF group showed much greater preservation of histological features, and TMs of the EGF group were thinner than spontaneously healed TMs. In conclusion, this novel EGF-CPS can be used as a nonsurgical intervention technique for treatment of chronic TM perforations.
机译:大多数慢性鼓膜(TM)穿孔都需要外科手术,例如鼓膜成形术,因为与急性穿孔不同,穿孔很难自发愈合。这项研究的目的是开发新的治疗技术和支架,这些支架和支架可以释放生长因子来治疗慢性TM穿孔。我们使用MTT分析评估了表皮生长因子(EGF)和成纤维细胞生长因子(FGF)对TM细胞体外培养的细胞增殖作用。它们都显示出相似的功效,因此我们使用EGF,因为它的成本较低。然后,我们根据先前的研究构建了可释放EGF的壳聚糖贴片支架(EGF-CPS)。我们分析了它的毒性和强度,并使用扫描电子显微镜对其进行了研究。 EGF在体外系统中从EGF-CPS释放8周。在动物研究中,接受EGF-CPS治疗的EGF组显示有56.5%的动物healing愈(13/23),而未接受任何治疗的对照组显示20.8%的healing愈(4/24) )(p = 0.04)。 EGF组的再生鼓膜的透射电镜研究表明,其组织学特征的保留程度更高,EGF组的TM较自发愈合的TM更薄。总之,这种新颖的EGF-CPS可以用作治疗慢性TM穿孔的非手术干预技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号